Cui Xinle, Cao Zhouhong, Wang Shuishu, Adler Stuart P, McVoy Michael A, Snapper Clifford M
The Institute for Vaccine Research and Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Vaccines (Basel). 2020 Apr 13;8(2):179. doi: 10.3390/vaccines8020179.
Human cytomegalovirus (HCMV) core fusion machinery proteins gB and gH/gL, and accessory proteins UL128/UL130/UL131A, are the key envelope proteins that mediate HCMV entry into and infection of host cells. To determine whether these HCMV envelope proteins could elicit neutralizing activities synergistically, we immunized rabbits with individual or various combinations of these proteins adsorbed to aluminum hydroxide mixed with CpG-ODN. We then analyzed serum neutralizing activities with multiple HCMV laboratory strains and clinical isolates. HCMV trimeric gB and gH/gL elicited high and moderate titers of HCMV neutralizing activity, respectively. HCMV gB in combination with gH/gL elicited up to 17-fold higher HCMV neutralizing activities compared to the sum of neutralizing activity elicited by the individual proteins analyzed with both fibroblasts and epithelial cells. HCMV gB+gH/gL+UL128/UL130/UL131A in combination increased the neutralizing activity up to 32-fold compared to the sum of neutralizing activities elicited by the individual proteins analyzed with epithelial cells. Adding UL128/UL130/UL131A to gB and gH/gL combination did not increase further the HCMV neutralizing activity analyzed with fibroblasts. These data suggest that the combination of HCMV core fusion machinery envelope proteins gB+gH/gL or the combination of gB and pentameric complex could be ideal vaccine candidates that would induce optimal immune responses against HCMV infection.
人巨细胞病毒(HCMV)核心融合机制蛋白gB和gH/gL以及辅助蛋白UL128/UL130/UL131A是介导HCMV进入并感染宿主细胞的关键包膜蛋白。为了确定这些HCMV包膜蛋白是否能协同引发中和活性,我们用吸附于氢氧化铝并与CpG-ODN混合的这些蛋白的单独或各种组合免疫兔子。然后我们用多种HCMV实验室菌株和临床分离株分析血清中和活性。HCMV三聚体gB和gH/gL分别引发了高和中等滴度的HCMV中和活性。与用成纤维细胞和上皮细胞分析的单个蛋白引发的中和活性之和相比,HCMV gB与gH/gL组合引发的HCMV中和活性高出多达17倍。与用上皮细胞分析的单个蛋白引发的中和活性之和相比,HCMV gB+gH/gL+UL128/UL130/UL131A组合使中和活性提高了多达32倍。将UL128/ULI30/UL131A添加到gB和gH/gL组合中,在用成纤维细胞分析时并没有进一步提高HCMV中和活性。这些数据表明,HCMV核心融合机制包膜蛋白gB+gH/gL组合或gB与五聚体复合物的组合可能是诱导针对HCMV感染的最佳免疫反应的理想候选疫苗。